| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 5 |
| 1 | ALLOPURINOL | 4 |
| 2 | REPAGLINIDE | 4 |
| 3 | ROSUVASTATIN | 4 |
| 4 | CLOPIDOGREL | 3 |
| 5 | CLOPIDOGREL BISULFATE | 3 |
| 6 | ESOMEPRAZOLE | 3 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 3 |
| 8 | ALIROCUMAB | 2 |
| 9 | ANTACID | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REPAGLINIDE | 4 | 0.0005 |
| 1 | GADODIAMIDE | 1 | 0.0003 |
| 2 | PARICALCITOL | 2 | 0.0001 |
| 3 | AGALSIDASE BETA | 1 | 0.0001 |
| 4 | SEVELAMER CARBONATE | 1 | 0.0001 |
| 5 | ALIROCUMAB | 2 | 0.0001 |
| 6 | TEDUGLUTIDE | 1 | 0.0001 |
| 7 | HEPARIN SODIUM | 1 | 0.0001 |
| 8 | ERYTHROPOIETIN | 1 | 0.0000 |
| 9 | ROSUVASTATIN | 4 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 5 |
| 1 | Glinide [EPC] | 4 |
| 2 | Xanthine Oxidase Inhibitor [EPC] | 4 |
| 3 | P2Y12 Platelet Inhibitor [EPC] | 3 |
| 4 | Proton Pump Inhibitor [EPC] | 3 |
| 5 | Complement Inhibitor [EPC] | 2 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 7 | PCSK9 Inhibitor [EPC] | 2 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 2 |
| 9 | Vitamin D Analog [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glinide [EPC] | 4 | 0.0004 |
| 1 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 2 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 3 | Vitamin D Analog [EPC] | 2 | 0.0001 |
| 4 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 6 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |